Eastgate Biotech (OTCMKTS:ETBI) Shares Cross Above 50 Day Moving Average – What’s Next?

by · The Cerbat Gem

Shares of Eastgate Biotech Corp. (OTCMKTS:ETBI – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Eastgate Biotech shares last traded at $0.00, with a volume of 132,000 shares.

Eastgate Biotech Stock Performance

About Eastgate Biotech

(Get Free Report)

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes.

Featured Articles